Zacks.com on MSN2d
Merck Q4 Earnings & Sales Beat Estimates, Stock Down on Weak '25 ViewMerck MRK reported fourth-quarter 2024 adjusted earnings per share (EPS) of $1.72, which beat the Zacks Consensus Estimate of $1.69. In the year-ago period, management reported adjusted EPS of 3 cents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback